| Hans-Günter Meyer-Thompson | International
USA. Travel Times to Opioid Addiction Programs Drive a Lack of Access to Treatment
USA. Travel Times to Opioid Addiction Programs Drive a Lack of Access to Treatment
If US pharmacies were permitted to dispense methadone for opioid use disorder (OUD) it would improve national access to treatment and save costs, new research suggests.
Under current federal regulations, only opioid treatment programs (OTPs) are permitted to dispense methadone maintenance treatment. This stands in sharp contrast to how methadone is dispensed in Canada, Australia, and the United Kingdom, where patients can obtain daily doses of methadone maintenance from community pharmacies. (Medscape, 20.07.2020)
USA. Travel Times to Opioid Addiction Programs Drive a Lack of Access to Treatment